Home Health TGEN North Ramps Up COVID-19 Testing Efforts

TGEN North Ramps Up COVID-19 Testing Efforts

by The 100 Companies

TGen North, located in Flagstaff, Ariz., which is also home to TGen’s Pathogen and Microbiome Division, has joined the worldwide effort to test for the SARS-CoV-2 virus that causes the COVID-19 disease.

Acting as genomic first responders, TGen is using advanced biomedical technologies to study this disease while also working to help establish a statewide tracking network for COVID-19. The organization received Emergency Use Authorization (EUA) from the Food & Drug Administration in March for its genomic-based test. TGen North and TGen in Phoenix are also busy conducting analyses of samples from suspected and symptomatic individuals for COVID-19 from select communities.

The Arizona 100 reports

These include Native American communities and special populations, such as long-term health care centers and even jail populations, to help provide support to these often-underserved groups who are most in need. Finally, through TGen, Arizona is moving to establish a comprehensive public health testing program for high-risk but asymptomatic individuals, such as health care workers on the first line of defense in combating this pandemic, who could be a dangerous reservoir for the virus.

Importantly, TGen tests were designed to not rely on the same “supply chain” as the federal government’s COVID-19 test kits. While this is an advantage for conducting the actual tests, TGen and other centers still face sample-collection issues, such as not having enough sample swabs. Regardless, TGen has a robust capacity to conduct COVID-19 testing, which is being scaled up. And, performing tests in Arizona reduces the time to report back results, compared to having to send samples outside of the state for testing.


You may also like

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

The Arizona 100